DNAJC17 deficiency: A novel inborn error of immunity with TNF-driven autoinflammation
Frontiers in Immunology · 09.07.2026 · 17
DOI: 10.3389/fimmu.2026.1751990 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Immunology, online erschienen am 09.07.2026. Verfasst von Fayhan Alroqi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Allergy and Immunology, Department of Pediatrics, King Abdullah Specialized Children's Hospital, King Abdulaziz Medical City, R…. Hauptthemen laut MEDLINE: HSP40 Heat-Shock Proteins, Inflammation, Molecular Chaperones, Tumor Necrosis Factor-alpha. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Inborn Errors of Immunity (IEI) encompass a broad spectrum of monogenic disorders with variable clinical presentations, including recurrent infections, autoimmunity, and systemic inflammation. Loss-of-function mutations in DNAJC17 have been previously linked to retinal dystrophy and hypogammaglobulinemia; however, the complete immunological phenotype and underlying autoinflammatory mechanisms remain poorly characterized.
Methods
We conducted a comprehensive clinical, molecular, and immunological investigation of three affected individuals from two unrelated consanguineous families. Our evaluation included whole genome sequencing with systematic exclusion of alternative genetic etiologies, quantitative analysis of DNAJC17 mRNA expression, and assessment of intracellular DNAJC17 protein levels. In addition, we performed in-depth immunophenotyping of adaptive and innate immune cell subsets, cytokine profiling, and interferon-stimulated gene expression analysis, alongside longitudinal evaluation of responses to therapeutic interventions.
Results
All three patients presented with early-onset retinitis pigmentosa, recurrent fever, lymphadenitis, and hypogammaglobulinemia. Sanger sequencing confirmed a homozygous variant (c.681G>A; p.Ala227=) in DNAJC17 resulting in exon 9 skipping. Comprehensive whole genome analysis excluded pathogenic variants in other immune-related genes. Quantitative RT-PCR demonstrated reduced DNAJC17 mRNA levels and flow cytometry showed decreased intracellular protein levels, consistent with a hypomorphic loss-of-function effect. Immunological evaluation revealed distinct abnormalities in T, B, and NK-cell subsets, with altered monocyte and dendritic cell populations indicating innate and adaptive immune dysregulation. Inflammatory profiling identified increased cytokine activity, including TNF-α and IL-6, alongside mild induction of interferon-stimulated genes. Conventional immunomodulatory therapies failed to achieve sustained remission. In contrast, TNF inhibitor therapy resulted in dramatic clinical improvement with normalization of inflammatory markers, sustained for over three years without significant adverse events.
Conclusion
Our findings establish DNAJC17 deficiency as a novel monogenic inborn error of immunity characterized by retinopathy, combined immunodeficiency, and TNF-driven autoinflammation responsive to targeted TNF blockade. The underlying immune abnormalities underscore the essential role of DNAJC17 in maintaining immune homeostasis and mitochondrial function. This work provides mechanistic insights into disease pathogenesis and establishes a rational, precision medicine therapeutic approach for this newly defined syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Allergy and Immunology, Department of Pediatrics, King Abdullah Specialized Children's Hospital, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
- King Abdullah International Medical Research Center, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
- College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
- Division of Pediatric Rheumatology, Department of Pediatrics, King Abdullah Specialized Children's Hospital, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
- Department of Pediatrics, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia.
- Clinical Laboratory Sciences Department, College of Applied Medical Sciences, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Zitieren
APA
Alroqi, F., Almojali, A., AlJaber, A. N., Althubaiti, N., Alzaaqi, S., Almohammadi, A., Albahkali, S., Majeed, M. A., Al Tuwaijri, A., Basmaeil, Y., Almutairi, A., & Alrasheed, A. (2026). DNAJC17 deficiency: A novel inborn error of immunity with TNF-driven autoinflammation. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1751990
Vancouver
Alroqi F, Almojali A, AlJaber AN, Althubaiti N, Alzaaqi S, Almohammadi A, et al. DNAJC17 deficiency: A novel inborn error of immunity with TNF-driven autoinflammation. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1751990
BibTeX
@article{Alroqi2026,
author = {Alroqi, Fayhan and Almojali, Abdullah and AlJaber, Abdulrahman N and Althubaiti, Nouf and Alzaaqi, Shouq and Almohammadi, Asayel and Albahkali, Sarah and Majeed, Mahmoud A and Al Tuwaijri, Abeer and Basmaeil, Yasser and Almutairi, Abduarahman and Alrasheed, Abdulrahman},
title = {DNAJC17 deficiency: A novel inborn error of immunity with TNF-driven autoinflammation},
journal = {Frontiers in Immunology},
year = {2026},
volume = {17},
doi = {10.3389/fimmu.2026.1751990}
}
EUVIMED